This Week in Cardiology

Nov 17 2023 This Week in Cardiology

Nov 17, 2023
Dr. John Mandrola reviews the SELECT, ORBITA2, and ARTESIA trials in this week's podcast. Topics include the potential of semaglutide in reducing CVD risk, the significance of the Orbita II trial in interventional cardiology, and the management of subclinical A-fib with anticoagulation therapy.
Ask episode
Chapters
Transcript
Episode notes